Paper2311368
ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis.
Plaisier AP and 4 others. Comput Methods Programs Biomed, 1990. Cited by 117 papers, by iCite.
Cite this record
ConductScience Library. ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis. Papers, record 2311368. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2311368
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Computer Simulation | Major topic |
| Insect Vectors | Major topic |
| Onchocerciasis, Ocular | Major topic |
| Simuliidae | Major topic |
| Animals | |
| Humans | |
| Microcomputers | |
| Software |
Source PubMed
Cited by61
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 117 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42749698 | Modelling anti-Ov16 seroprevalence for the control and elimination of onchocerciasis. | Nat Commun | 2026 | https://conductscience.org/library/papers/42749698 | PubMed |
| 42539045 | Modelling the impact of mass drug administration with ivermectin or moxidectin on human onchocerciasis when there is sub-optimal response of parasites to treatment. | Res Sq | 2026 | https://conductscience.org/library/papers/42539045 | PubMed |
| 41671175 | Important entomological events in the history of onchocerciasis ('river blindness'). | Int Health | 2026 | https://conductscience.org/library/papers/41671175 | PubMed |
| 39185442 | Inference of essential genes in Brugia malayi and Onchocerca volvulus by machine learning and the implications for discovering new interventions. | Comput Struct Biotechnol J | 2024 | https://conductscience.org/library/papers/39185442 | PubMed |
| 37235598 | Onchocerciasis-associated epilepsy in Maridi, South Sudan: Modelling and exploring the impact of control measures against river blindness. | PLoS Negl Trop Dis | 2023 | https://conductscience.org/library/papers/37235598 | PubMed |
| 35020729 | Demographic patterns of human antibody levels to Simulium damnosum s.l. saliva in onchocerciasis-endemic areas: An indicator of exposure to vector bites. | PLoS Negl Trop Dis | 2022 | https://conductscience.org/library/papers/35020729 | PubMed |
| 34310602 | The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030. | PLoS Negl Trop Dis | 2021 | https://conductscience.org/library/papers/34310602 | PubMed |
| 34157020 | Human immune response against salivary antigens of Simulium damnosum s.l.: A new epidemiological marker for exposure to blackfly bites in onchocerciasis endemic areas. | PLoS Negl Trop Dis | 2021 | https://conductscience.org/library/papers/34157020 | PubMed |
| 34115752 | How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment? | PLoS Negl Trop Dis | 2021 | https://conductscience.org/library/papers/34115752 | PubMed |
| 33979331 | The impact of mass drug administration expansion to low onchocerciasis prevalence settings in case of connected villages. | PLoS Negl Trop Dis | 2021 | https://conductscience.org/library/papers/33979331 | PubMed |
| 33289025 | Feasibility of Onchocerciasis Elimination Using a "Test-and-not-treat" Strategy in Loa loa Co-endemic Areas. | Clin Infect Dis | 2021 | https://conductscience.org/library/papers/33289025 | PubMed |
| 32173745 | Structural Uncertainty in Onchocerciasis Transmission Models Influences the Estimation of Elimination Thresholds and Selection of Age Groups for Seromonitoring. | J Infect Dis | 2020 | https://conductscience.org/library/papers/32173745 | PubMed |
| 32043442 | The Interruption of Transmission of Human Onchocerciasis by an Annual Mass Drug Administration Program in Plateau and Nasarawa States, Nigeria. | Am J Trop Med Hyg | 2020 | https://conductscience.org/library/papers/32043442 | PubMed |
| 31805049 | Modelling exposure heterogeneity and density dependence in onchocerciasis using a novel individual-based transmission model, EPIONCHO-IBM: Implications for elimination and data needs. | PLoS Negl Trop Dis | 2019 | https://conductscience.org/library/papers/31805049 | PubMed |
| 31304961 | Projected Number of People With Onchocerciasis-Loiasis Coinfection in Africa, 1995 to 2025. | Clin Infect Dis | 2020 | https://conductscience.org/library/papers/31304961 | PubMed |
| 31062838 | Predictive Value of Ov16 Antibody Prevalence in Different Subpopulations for Elimination of African Onchocerciasis. | Am J Epidemiol | 2019 | https://conductscience.org/library/papers/31062838 | PubMed |
| 30646934 | Entomological assessment of the transmission following recrudescence of onchocerciasis in the Comoé Valley, Burkina Faso. | Parasit Vectors | 2019 | https://conductscience.org/library/papers/30646934 | PubMed |
| 30522129 | Predicted short and long-term impact of deworming and water, hygiene, and sanitation on transmission of soil-transmitted helminths. | PLoS Negl Trop Dis | 2018 | https://conductscience.org/library/papers/30522129 | PubMed |
| 30296264 | The effect of assortative mixing on stability of low helminth transmission levels and on the impact of mass drug administration: Model explorations for onchocerciasis. | PLoS Negl Trop Dis | 2018 | https://conductscience.org/library/papers/30296264 | PubMed |
| 30226900 | Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa. | PLoS Negl Trop Dis | 2018 | https://conductscience.org/library/papers/30226900 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2311368
GET https://conductscience.org/api/papers/v1/2311368/cited_by?page=2